rs202031219
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 4P and 14B. PM1PM5BP4_ModerateBP6_Very_StrongBS2
The NM_000321.3(RB1):c.1967G>A(p.Arg656Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000725 in 1,613,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R656M) has been classified as Pathogenic.
Frequency
Consequence
NM_000321.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1967G>A | p.Arg656Gln | missense_variant | 20/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.1967G>A | p.Arg656Gln | missense_variant | 20/27 | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1967G>A | p.Arg656Gln | missense_variant | 20/27 | 1 | NM_000321.3 | ENSP00000267163.4 | ||
RB1 | ENST00000650461.1 | c.1967G>A | p.Arg656Gln | missense_variant | 20/27 | ENSP00000497193.1 | ||||
RB1 | ENST00000643064.1 | c.192+78251G>A | intron_variant | ENSP00000496005.1 |
Frequencies
GnomAD3 genomes AF: 0.0000792 AC: 12AN: 151568Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251446Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135916
GnomAD4 exome AF: 0.0000718 AC: 105AN: 1461812Hom.: 0 Cov.: 33 AF XY: 0.0000770 AC XY: 56AN XY: 727218
GnomAD4 genome AF: 0.0000792 AC: 12AN: 151568Hom.: 0 Cov.: 30 AF XY: 0.0000811 AC XY: 6AN XY: 73980
ClinVar
Submissions by phenotype
Retinoblastoma Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Dec 18, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | RB1: BS1 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at